中文 | English
Return
Total: 304 , 1/31
Show Home Prev Next End page: GO
Author:(XU LINGLING)

1.Adverse effects, pathogenesis and treatment of anti-angiogenetic targeting agents

Lingling XU

Journal of International Oncology 2010;37(3):196-199

2.Analysis of Drugs Used in 10 Hospitals of Hunan Province From 1996 to 2000

Anying LU ; Lingling XU

China Pharmacy 2001;12(4):223-224

3.Circulating microRNA in colorectal cancer

Lingling XU ; Jing WU

Journal of International Oncology 2012;39(10):769-772

4.Association of human ghrelin gene polymorphism with type 2 diabetes mellitus

Lingling XU ; Hongding XIANG

Basic & Clinical Medicine 2006;0(01):-

5.Progress in Clinical Research on Novel PD-1 inhibitor Nivolumab

Lingling DU ; Jiajun XU

China Pharmacist 2015;(11):1971-1974

6.Effect of Yulin Mixture on Ovarian Function in Rats with Kidney-yang Deficiency Ovulatory Dysfunction

Yuxuan ZHANG ; Lingling XU

China Pharmacist 2017;20(4):621-623

7.Analysis of Drugs Utilization of Inpatients in Neurology Department of Our Hospital

Ling WANG ; Lingling XU

China Pharmacy 2007;0(30):-

8.Promotive effect of puerarin on melanogenesis in melanocytes and its possible mechanisms

Lingling ZHANG ; Wen XU ; Ai'e XU ;

Chinese Journal of Dermatology 2016;49(5):338-341

9.The role of T-lymphocytes in ischemic brain injury

Lingling LI ; Lan YE ; Yun XU

International Journal of Cerebrovascular Diseases 2009;17(8):636-640

10.Risk factors in elderly thermal burn patients with acute ischemic stroke

Lingling XU ; Xin WANG ; Bin ZHANG

Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2017;19(6):611-614

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 304 , 1/31 Show Home Prev Next End page: GO